Cerity Partners LLC raised its position in Intel Corporation (NASDAQ:INTC – Free Report) by 27.4% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 1,579,838 shares of the chip maker’s stock after acquiring an additional 339,495 shares during the period. Cerity Partners LLC’s holdings in Intel were worth $53,015,000 as of its most recent filing with the SEC.
Several other hedge funds also recently made changes to their positions in INTC. SeaBridge Investment Advisors LLC acquired a new stake in shares of Intel in the third quarter valued at approximately $694,000. CoreCap Advisors LLC grew its position in Intel by 15.5% in the third quarter. CoreCap Advisors LLC now owns 18,473 shares of the chip maker’s stock valued at $620,000 after purchasing an additional 2,473 shares in the last quarter. BCS Wealth Management acquired a new stake in Intel in the 3rd quarter valued at $210,000. Kathmere Capital Management LLC lifted its position in Intel by 14.3% during the 3rd quarter. Kathmere Capital Management LLC now owns 10,446 shares of the chip maker’s stock worth $350,000 after buying an additional 1,308 shares in the last quarter. Finally, Gladstone Institutional Advisory LLC lifted its position in Intel by 4.0% during the 3rd quarter. Gladstone Institutional Advisory LLC now owns 49,069 shares of the chip maker’s stock worth $1,646,000 after buying an additional 1,893 shares in the last quarter. 64.53% of the stock is owned by institutional investors.
Intel News Summary
Here are the key news stories impacting Intel this week:
- Positive Sentiment: Intel debuted its Panther Lake/Core Ultra Series 3 processors — the first built on its 18A process — at CES, with strong performance and gaming demos that support Intel’s manufacturing comeback narrative. Stock Market Today, Jan. 7: Intel Surges After Panther Lake AI PC Chips Spark Investor Optimism
- Positive Sentiment: NVIDIA completed a multi-billion-dollar share purchase of Intel last month; markets view that stake as a vote of confidence and a strategic alignment for AI-related product cycles. Nvidia’s (NVDA) Investment in Intel Supports Its 2026 Bull Thesis
- Positive Sentiment: Analysts have been upgrading coverage after the CES reveals (example: Melius Research / others raising ratings and price targets), adding momentum to the rally. Melius Upgrades Intel (NASDAQ:INTC) to “Buy”
- Positive Sentiment: Unusually large call option activity (roughly 792,840 calls traded) signals speculative/institutional bullish positioning ahead of follow-on catalysts. (Market options flow entry)
- Neutral Sentiment: Intel confirmed a scheduled release of Q4 and full-year 2025 results — an upcoming earnings date that could reinforce or reverse the current optimism. Intel to Report Fourth-Quarter and Full-Year 2025 Financial Results
- Neutral Sentiment: Coverage pieces and explainers are evaluating whether Intel’s turnaround is truly sustainable — these narratives can amplify moves but leave clarity pending on margin and foundry growth details. Intel Stock Is Soaring. Is the Turnaround Gamble Finally Paying Off?
- Negative Sentiment: Execution risk remains: delivering volume, sustained 18A yields, and competitive pressure from AMD/NVIDIA in PC and AI markets are real downsides if Intel stumbles on ramp or pricing. Intel Enters Handheld Gaming Wars With Dedicated New Processor
Intel Stock Up 6.5%
Intel (NASDAQ:INTC – Get Free Report) last released its quarterly earnings data on Thursday, October 23rd. The chip maker reported $0.23 EPS for the quarter. The firm had revenue of $13.65 billion during the quarter, compared to analysts’ expectations of $13.10 billion. Intel had a net margin of 0.37% and a negative return on equity of 0.75%. The company’s revenue for the quarter was up 3.0% compared to the same quarter last year. During the same period in the previous year, the business posted ($0.46) earnings per share. Intel has set its Q4 2025 guidance at 0.080-0.080 EPS. As a group, research analysts expect that Intel Corporation will post -0.11 earnings per share for the current year.
Analysts Set New Price Targets
A number of analysts recently issued reports on the company. Sanford C. Bernstein reaffirmed a “neutral” rating on shares of Intel in a research report on Tuesday, November 18th. Loop Capital boosted their price target on Intel from $25.00 to $40.00 and gave the stock a “hold” rating in a research report on Friday, October 24th. Mizuho upped their price objective on Intel from $39.00 to $41.00 and gave the stock a “neutral” rating in a research note on Friday, October 24th. Cowen reissued a “hold” rating on shares of Intel in a research note on Friday, October 24th. Finally, Hsbc Global Res lowered shares of Intel from a “hold” rating to a “moderate sell” rating in a research report on Tuesday, October 7th. Four research analysts have rated the stock with a Buy rating, twenty-four have issued a Hold rating and eight have given a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Reduce” and a consensus price target of $35.88.
View Our Latest Analysis on Intel
Intel Profile
Intel Corporation, founded in 1968 by Robert Noyce and Gordon E. Moore and headquartered in Santa Clara, California, is a leading global designer and manufacturer of semiconductor products. The company is historically notable for introducing the first commercial microprocessor and for driving the x86 architecture that underpins many personal computers and servers. Intel’s core business spans the design, fabrication and marketing of processors, chipsets and related components for a wide range of computing applications.
Intel’s product portfolio includes client and mobile processors marketed under brands such as Intel Core and Pentium, as well as high-performance Xeon processors for data centers and cloud infrastructure.
See Also
- Five stocks we like better than Intel
- You Still Think Silver’s a Joke? Watch What Happens Next.
- A U.S. “birthright” claim worth trillions – activated quietly
- A month before the crash
- Wall Street ‘Sleeper Stock’ Could Become #1 Stock of 2026
- YDES Could Be 2026’s Biotech Breakthrough
Receive News & Ratings for Intel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intel and related companies with MarketBeat.com's FREE daily email newsletter.
